19MA016N Immunotherapy: Combination Therapy Using BRAF Inhibitors with Immunotherapy to Treat RAS Mutant Driven Cancers
FOR MORE INFORMATION ON THIS TECHNOLOGY, PLEASE CONTACT OUR OFFICE
The Innovation Office
InnovationMarketing@Moffitt.org
(813) 745-6828